Key Findings:  Resulting data revealed that chronic exposure to 5-HT increased visceromotor response to colorectal distention and worsened colitis (which was associated with decrease of AEA via 5-HT3 and 5-HT4 receptors). As such, the authors posit that reducing 5-HT signaling or supplementation with endocannabinoids in the gut may induce therapeutic effects in severe cases of abdominal pain with IBD.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Canada, Italy, Poland
Year of Pub:  2019
Cannabinoids Studied:  Anandamide (AEA), Endocannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Ligands Studied:  Serotonin
Citation:  Salaga M, et al. Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system. Biochem Pharmacol. 2019; 161:37-51. doi: 10.1016/j.bcp.2019.01.001
Authors:  Salaga M, Binienda A, Piscitelli F, Mokrowiecka A, Cygankiewicz AI, Verde R, Malecka-Panas E, Kordek R, Krajewska WM, Di Marzo V, Fichna J